KRT14 and neoplasm: To further explore the anti-angiogenic potential of HoxA5 during de novo tumor progression where early development of angiogenic vasculature accompanies neoplastic progression, we intercrossed HoxA5-tTA mice with a mouse model of de novo squamous carcinogenesis, e.g., K14-HPV16 mice [13].